Table 5.
Antimicrobial activity of resveratrol and its derivatives.
| Compound | Experimental model | Microbial or animal type | Outcomes offered by the compound | Reference |
|---|---|---|---|---|
| Resveratrol | In vitro susceptibility | Dermatophytes | Resveratrol effectively retarded dermatophyte growth | [152] |
| Resveratrol | In vivo skin infection | HSV | Resveratrol mitigated skin lesion caused by HSV | [155] |
| Oxyresveratrol | In vivo skin infection | HSV | Oxyresveratrol delayed the development of skin lesion caused by HSV | [156] |
| Pterostilbene | In vitro susceptibility and in vivo skin infection | MRSA | Pterostilbene showed superior MRSA growth inhibition than resveratrol | [157] |
| Resveratrol and gallic acid in liposomes | In vitro skin absorption and microbial inhibition | Skin pathogens | Liposomes improved antimicrobial activity of resveratrol | [158] |
HSV, herpes simplex virus; MRSA, methicillin-resistant Staphylococcus aureus.